PTC Therapeutics (PTCT) PT Lowered to $25 at Barclays
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $71.70 -0.38%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays analyst Gena Wang lowered the price target on PTC Therapeutics (NASDAQ: PTCT) to $25.00 (from $26.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- PTC Therapeutics (PTCT) PT Raised to $122 at Barclays
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
- Lithium Ionic Corp (LTH:CN) PT Lowered to Cdn$2.50 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
